Merck (MRK) and Ridgeback Biotherapeutics announced today that their COVID-19 pill — the first oral antiviral of its kind — cut the risk of hospitalizations or deaths by half, and that they would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback